Hypocellular myelodysplastic syndromes and hypocellular acute myeloid leukemia: Relationship to aplastic anemia

The Myelodysplastic Syndromes: Pathobiology and Clinical Management

Volumn , Issue , 2002, Pages 121-138

  Tomonaga, Masao ^a   Nagai, Kazuhiro ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0142210328     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (40)

1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51:189-199.
2. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 1976; 33:451-458.
3. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting—Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17:3835-3849.
4. Yoshida Y, Oguma S, Uchino H, Maekawa T. Refractory myelodysplastic anaemias with hypocellular bone marrow. J Clin Pathol 1988; 41:763-767.
5. Toyama K, Ohyashiki K, Yoshida Y, Abe T, Asano S, Hirai H, Hirashima K, Hotta T, Kuramoto A, Kuriya S, Miyazaki T, Kakishita E, Mizoguchi H, Mori M, Shira-kawa S, Takaku F, Tomonaga M, Uchino H, Urabe A, Yasunaga K, Nomura T. Clinical and cytogenetic findings of myelodysplastic syndromes showing hypocellular bone marrow or minimal dysplasia, in comparison with typical myelodysplastic syndromes. Int J Hematol 1993; 58:53-61.
6. Tuzuner N, Cox C, Rowe JM, Watrous D, Bennett JM. Hypocelluler myelodysplastic syndromes (MDS): new proposals. Br J Haematol 1995; 91:612-617.
7. Elghetany MT, Hudnall SD, Gardner FH. Peripheral blood picture in primary hypocellular refractory anemia and idiopathic acquired aplastic anemia: an additional tool for differential diagnosis (review). Haematologica 1997; 82:21-24.
8. Goyal R, Qawi H, Ali I, Dar S, Mundle S, Shetty V, Mativi Y, Allampallam K, Lisak L, Loew J, Venugopal P, Gezer S, Robin E, Rifkin S, Raza A. Biologic characteristics of patients with hypocellular myelodysplastic syndromes. Leuk Res 1999; 23:357-364.
9. Beard MEJ; Bateman CJT, Crowther DC, Wrigley PFM, Whitehouse JMA, Fairley GH, Scott RB. Hypoplastic acute myelogenous leukaemia. Br J Haematol 1975; 31: 167-176.
10. Howe RB, Bloomfield CD, McKenna RW. Hypocellular acute leukemia. Am J Med 1982; 72:391-395.
11. Needleman SW, Burns CP, Dick FR, Armitage JO. Hypoplastic acute leukemia. Cancer 1981; 48:1410-1414.
12. Gladson CL, Naeim F. Hypocellular bone marrow with increased blasts. Am J Hem-atol 1986; 21:15-22.
13. Nagai K, Kohno T, Chen YX, Tsushima H, Mori H, Nakamura H, Jinnai I, Matsuo T, Kuriyama K, Tomonaga M, Bennett JM. Diagnostic criteria for hypocellular acute leukemia: a clinical entity distinct from overt acute leukemia and myelodysplastic syndrome. Leuk Res 1996; 20:563-574.
14. Tuzuner N, Cox C, Rowe JM, Bennett JM. Hypocellular acute myeloid leukemia: the Rochester (New York) experience. Hematol Pathol 1995; 9:195-203.
15. Hartsock RJ, Smith EB, Petty CS. Normal variations with aging of the amount of hematopoietic tissue in bone marrow from the anterior iliac crest. Am J Clin Pathol 1965; 43:326-331.
16. Tuzuner N, Bennett JM. Reference standards for bone marrow cellularity. Leuk Res 1994; 18:645-647.
17. Tuzuner N, Cox C, Rowe JM, Bennett JM. Bone marrow cellularity in myeloid stem cell disorders: impact of age correction. Leuk Res 1994; 18:559-564.
18. Kusumoto S, Jinnai I, Matsuda A, Murohashi I, Bessho M, Saito M, Hirashima K, Heshiki A, Minamihisamatsu M. Bone marrow patterns in patients with aplastic anaemia and myelodysplastic syndrome: observations with magnetic resonance imaging. Eur J Haematol 1997; 59:155-161.
19. Schick F, Weiss B, Einsele H. Magnetic resonance imaging reveals a markedly inho-mogeneous distribution of marrow cellularity in a patient with myelodysplasia. Ann Hematol 1995; 71:143-146.
20. Lorand-Metze I, Santiago GF, Lima CS, Zanardi VA, Torriani M. Magnetic resonance imaging of femoral marrow cellularity in hypocellular haemopoietic disorders. Clin Radiol 2001; 56:107-110.
21. Molldrem JJ, Caples M, Mavroudis D, Plante M, Young NS, Barrett AJ. Antithymocyte globulin for patients with myelodysplastic syndrome. Br J Haematol 1997; 99: 699-705.
22. Molldrem JJ, Jiang YZ, Stetler-Stevenson M, Mavroudis D, Hensel N, Barrett AJ. Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFU-GM and alterations in T-cell receptor Vbeta profiles. Br J Haematol 1998; 102: 1314-1322.
23. Jonasova A, Neuwirtova R, Cermak J, Vozobulova V, Mocikova K, Siskoua M, Hochova I. Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow. Br J Haematol 1998; 100:304-309.
24. Barrett J, Saunthararajah Y, Molldrem J. Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology? (review). Semin Hematol 2000; 37:15-29.
25. Iwanaga M, Sadamori N, Amenomori T, Kawaguchi Y, Nakamura H, Matsuo T, Kuriyama K, Tomonaga M. A new translocation (4;l2)(q2l;ql5) after combined immunosuppressive therapy in a case of hypoplastic myelodysplastic syndrome with translocation (12; l5)(q23; ql2). Cancer Genet Cytogenet 1998; 107:82-84.
26. Socie G, Henry-Amar M, Bacigalupo A, Hows J, Tichelli A, Ljungman P, McCann SR, Frickhofen N, Van’t Veer-Korthof E, Gluckman E. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party. N Engl J Med 1993; 329:1152-1157.
27. Fuchigami K, Mori H, Matsuo T, Iwanaga M, Nagai K, Kuriyama K, Tomonaga M. Absolute number of circulating CD34+ cells is abnormally low in refractory anemias and extremely high in RAEB and RAEB-t; novel pathologic features of myelodysplastic syndromes identified by highly sensitive flow cytometry. Leuk Res 2000; 24:163-174.
28. Sato T, Kim S, Selleri C, Young NS, Maciejewski JP. Measurement of secondary colony formation after 5 weeks in long-term cultures in patients with myelodysplas-tic syndrome. Leukemia 1999; 12:1187-1194.
29. Tagawa M, Shibata J, Tomonaga M, Amenomori T, Yoshida Y, Kuriyama K, Matsuo T, Sadamori N, Ichimaru M. Low-dose cytosine arabinoside regimen induced a complete remission with normal karyotypes in a case with hypoplastic acute myeloid leukaemia with No. 8-trisomy: in vitro and in vivo evidence for normal haematopoietic recovery. Br J Haematol 1985; 60:449-455.
30. Kohno T, Nagai K, Tsukasaki K, Jinnai I, Tomonaga M, Ichimaru M, Tagawa M. [Effects of low dose Ara-C regimen in acute leukemias and RAEB.] Rinsho Ketsueki 1989; 30:638-643 [Japanese].
31. Kanamori H, Maruta A, Miyashita H, Harano H, Fukawa H, Matsuzaki M, Moto-mura S, Mohri H, Kodama F, Okubo T. Low-dose cytosine arabinoside for treating hypocellular acute leukemia in the elderly. Am J Hematol 1992; 39:52-55.
32. Suzan F, Terre C, Garcia I, Bastie JN, Baumelou E, Gluckman E, Castaigne S. Three cases of typical aplastic anaemia associated with a Philadelphia chromosome. Br J Haematol 2001; 112:385-387.
33. Kojima S, Tsuchida M, Matsuyama T. Myelodysplasia and leukemia after treatment of aplastic anemia with G-CSF. N Engl J Med 1992; 326:1294-1295.
34. Kojima S, Hibi S, Kosaka Y, Yamamoto M, Tsuchida M, Mugishima H, Sugita K, Yabe H, Ohara A, Tsukimoto I. Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia. Blood 2000; 96:2049-2054.
35. Ohara A, Kojima S, Hamajima N, Tsuchida M, Imashuku S, Ohta S, Sasaki H, Okamura J, Sugita K, Kigasawa H, Kiriyama Y, Akatsuka J, Tsukimoto I. Myelody-splastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia. Blood 1997; 90:1009-1013.
36. Kaito K, Kobayashi M, Katayama T, Masuoka H, Shimada T, Nishiwaki K, Sekita T, Otsubo H, Ogasawara Y, Hosoya T. Long-term administration of G-CSF for aplastic anaemia is closely related to the early evolution of monosomy 7 MDS in adults. Br J Haematol 1998; 103:297-303.
37. Kojima S, Nakao S, Tomonaga M, Hows J, Marsh J, Gerard S, Bacigalupo A, Mizo-guchi H. Consensus conference on the treatment of aplastic anemia (review). Int J Hematol 2000; 72:118-123.
38. Matsuo Y, Iwanaga M, Mori H, Yoshida S, Kawaguchi Y, Yakata Y, Murata K, Nagai K, Jinnai I, Matsuo T, Kuriyama K, Tomonaga M. Recovery of hematopoietic progenitor cells in patients with severe aplastic anemia who obtained good clinical response with a combination therapy of immunosuppressive agents and recombinant human granulocyte colony-stimulating factor. Int J Hematol 2000; 72:37-43.
39. Geary CG, Harrison CJ, Philpott NJ, Hows JM, Gordon-Smith EC, Marsh JC. Abnormal cytogenetic clones in patients with aplastic anaemia: response to immunosuppressive therapy. Br J Haematol 1999; 104:271-274.
40. Elghetany MT, Vyas S, Yuoh G. Significance of p53 overexpression in bone marrow biopsies from patients with bone marrow failure: aplastic anemia, hypocellular refractory anemia, and hypercellular refractory anemia. Ann Hematol 1998; 77:261-264.